bih.button.backtotop.text
BROWSE BY TEST NAME
%
1
2
3
5
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Clear
 
Test Code:
090-21-0741-01

Order Name:
Glycomark (1.5 anhydroglucitol) **

 
Useful For:
The test  is indicated for the intermediate term monitoring of glycemic control in people with diabetes.
 
Methodology:
Cobas c502 analyzer
 
 
 
Test Code:
090-21-0741-01

Order Name:
Glycomark (1.5 anhydroglucitol) **

 
Patient Preparation:
Non-fasting 
 
Collection Specimen Or Container:
Blood/ Plain blood (Red top) 6 mL, 1 tube
 
Specimen Testing Type:
Serum, minimum volume 2 mL
 
Sub Mission Container:
Plastic tube
 
 
 
Test Code:
090-21-0741-01

Order Name:
Glycomark (1.5 anhydroglucitol) **

 
Method detail:
Cobas c502 analyzer
 
Schedule:
N/A **Sent Out to N Health
 
Turnaround Time:
Received specimen to report within 1-2 days
 
Performing Location:
N Health
Referral Lab Services, Laboratory Department 14160-2
 
 
 
Test Code:
090-21-0741-01

Order Name:
Glycomark (1.5 anhydroglucitol) **

 
 
Clinical Information:
The Glycomark  test provides quantitative measurement of 1,5-anhydroglucitol (1,5-AG) in serum . The test  is indicated for the intermediate term monitoring of glycemic control in people with diabetes.

Tight glycemic control is essential for preventing the complications of diabetes. The clinical standard for evaluating glycemic control is the measurement of hemoglobin A1c (HbA1c); elevated levels (>7.0%) indicate significant hyperglycemia. However, even in patients with well-controlled HbA1c levels, postprandial glucose levels may be significantly elevated and lowering these will further improve control.

1,5-Anhydroglucitol (1,5-AG) is a glucose-like monosaccharide contained in food. Intake is normally balanced with urinary excretion; however, during periods of hyperglycemia, glucose blocks reabsorption of 1,5-AG in the renal tubules. Thus, low blood levels of 1,5-AG are associated with hyperglycemia. 1,5-AG levels change more rapidly than HbA1c levels and reflect glycemia over the previous 1-2 week period.
 
Reference Value:
Male : 10.7-32.0 ug/mL, Female : 6.8-29.3 ug/mL
 
Clinical Reference:
N Health Laboratory Catalog 2017